» Articles » PMID: 15253918

Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors

Overview
Publisher Wiley
Specialty Oncology
Date 2004 Jul 16
PMID 15253918
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Survivors of childhood and adolescent cancer are one of the higher risk populations seen by health care professionals. The curative therapy administered for the cancer also affects growing and developing tissues. Following chemotherapy, radiation therapy, and surgery, many survivors will experience chronic or late-occurring health problems, often not becoming clinically apparent until decades after therapy. Survivors face an increased risk of morbidity, mortality, and diminished quality of life associated with their previous cancer therapy. Risk is further modified by the survivor's genetics, lifestyle habits, and comorbid health conditions. Over their lifetime, survivors will see health care professionals from an array of specialties and disciplines. The aim of this review is threefold: (1) to convey a sense of the risk faced by survivors to clinicians unfamiliar with the population; (2) to provide an up-to-date tool for clinicians, regardless of specialty or discipline, when providing care for a survivor; and (3) to complement the recently completed recommendations for screening, prevention, and management of childhood cancer survivors.

Citing Articles

Mechanical properties of pediatric low-grade gliomas in children with and without neurofibromatosis type 1.

McIlvain G, Hayes L, Walter A, Averill L, Kandula V, Johnson C Neuroradiology. 2024; 66(12):2301-2311.

PMID: 39432071 PMC: 11611943. DOI: 10.1007/s00234-024-03491-z.


Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.

Abrahao R, Brunson A, Chubak J, Wernli K, Nichols H, Chao C Thromb Res. 2024; 235:1-7.

PMID: 38244373 PMC: 10989999. DOI: 10.1016/j.thromres.2024.01.002.


Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

Muto S, Matsubara T, Inoue T, Kitamura H, Yamamoto K, Ishii T Int J Clin Oncol. 2023; 28(10):1259-1297.

PMID: 37382749 DOI: 10.1007/s10147-023-02372-4.


Pediatric Rhabdomyosarcomas of the Genitourinary Tract.

Castle J, Levy B, Allison D, Rodeberg D, Rellinger E Cancers (Basel). 2023; 15(10).

PMID: 37345202 PMC: 10216134. DOI: 10.3390/cancers15102864.


Comorbidity Differences by Trajectory Groups as a Reference for Identifying Patients at Risk for Late Mortality in Childhood Cancer Survivors: Longitudinal National Cohort Study.

Kim H, Kim H, Kang S, Koh K, Im H, Park Y JMIR Public Health Surveill. 2023; 9:e41203.

PMID: 36754630 PMC: 10131914. DOI: 10.2196/41203.